If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> ASPERGILLOSIS<br /> <br /> <br /> <br /> Adapted from:<br /> IDSA Guidelines<br /> Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis:<br /> clinical practice guidelines of the Infectious Diseases Society of<br /> America. Clin Infect Dis. 2008;46:327-360.<br /> <br /> <br /> <br /> <br /> <br /> Key Points<br /> <br /> Diagnosis<br /> <br /> Selecting a Treatment Regimen<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> www.GuidelineCentral.com<br /> Key Points<br /> ÎAspergillus spp infection is a major cause of morbidity and mortality in<br /> immunocompromised patients<br /> ÎInvasive aspergillosis (IA) involves
ASPERGILLOSISAdapted from:IDSA GuidelinesWa
ASPERGILLOSISAdapted from:IDSA GuidelinesWa
Key PointsÎAspergillus spp infection is a major
Key PointsÎAspergillus spp infection is a major
Empirical or Pre-Emptive Therapy in Neutropenic P
Empirical or Pre-Emptive Therapy in Neutropenic P
DiagnosisDiagnosis of Invasive AspergillosisDet
DiagnosisDiagnosis of Invasive AspergillosisDet
Selecting a Treatment RegimenTable 3. Relative I
Selecting a Treatment RegimenTable 3. Relative I
Selecting a Treatment Regimen
Selecting a Treatment Regimen
EarlyTreatmentandPreventionofIAinHigh-
EarlyTreatmentandPreventionofIAinHigh-
Selecting a Treatment RegimenTable 1. Antifungal
Selecting a Treatment RegimenTable 1. Antifungal
CommentsCausesacuteinfusion-relatedreactions—f
CommentsCausesacuteinfusion-relatedreactions—f
Selecting a Treatment RegimenTable 2. Recommen
Selecting a Treatment RegimenTable 2. Recommen
yaAlternativeb
yaAlternativeb
To view more eGuidelineViewers please visit:ww
To view more eGuidelineViewers please visit:ww